The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fracture risk after radium-223 (Ra-223) in metastatic castration resistant prostate cancer (mCRPC).
 
Roberto Alonzi
Travel, Accommodations, Expenses - Bayer; Janssen
 
Chris C. Parker
Honoraria - Advanced Accelerator Applications; Bayer; Janssen
Consulting or Advisory Role - Bayer Schering Pharma; Janssen
Research Funding - Bayer Schering Pharma (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Janssen
 
Nina Tunariu
Consulting or Advisory Role - Astellas Oncology; Bayer; Janssen
Speakers' Bureau - Astellas Oncology; Bayer; Janssen; Sanofi
 
Dow-Mu Koh
Speakers' Bureau - Bayer
 
John Staffurth
No Relationships to Disclose
 
Matthew D. Blackledge
Patents, Royalties, Other Intellectual Property - Institute of Cancer Research (Inst)
 
Anwar R. Padhani
Honoraria - Janssen Oncology; Roche Pharma AG; Siemens Healthcare Diagnostics
Travel, Accommodations, Expenses - Bracco Diagnostics; Janssen Oncology; Siemens Healthcare Diagnostics
 
Alison Tree
Honoraria - Astellas Oncology; Bayer; Ferring; Genesis Healthcare Partners; Janssen
Research Funding - Elekta; MSD
Travel, Accommodations, Expenses - Astellas Oncology; Elekta; Janssen
 
Helen Stidwill
No Relationships to Disclose
 
Jessica Finch
No Relationships to Disclose
 
Peter Chatfield
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen-Cilag (Inst)
 
Sophie Perry
Employment - Astellas Pharma (I); GlaxoSmithKline UK Ltd. (I)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen-Cilag (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Holly Tovey
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Janssen-Cilag (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Employees of the ICR are subject to a "Rewards to Inventors Scheme" which may reward contributors to a programme that is subsequently licensed.
 
Emma Hall
Research Funding - Accuray (Inst); Alliance Pharma (Inst); AstraZeneca (Inst); Aventis Pharma (Inst); Bayer (Inst); Kyowa Hakko Kirin (Inst); Merck Sharp & Dome (Inst)